Hospital Universitario Príncipe de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

    The Lancet Regional Health - Europe, Vol. 28

2017

  1. International variability in gastrointestinal decontamination with acute poisonings

    Pediatrics, Vol. 140, Núm. 2